Having trouble accessing articles? Reset your cache.

N9-GP: Phase III data

The single-blind, international Phase III paradigm 2 trial in 74 patients with hemophilia B showed that once-weekly 10 and 40 U/kg

Read the full 217 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE